Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade.
The company’s stock has a 5-day price change of -3.56% and 1.61% over the past three months. BMY shares are trading 0.51% year to date (YTD), with the 12-month market performance up to 15.41% higher. It has a 12-month low price of $39.35 and touched a high of $61.10 over the same period. BMY has an average intraday trading volume of 11.20 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.81%, -1.52%, and 13.28% respectively.
Institutional ownership of Bristol-Myers Squibb Co (NYSE: BMY) shares accounts for 77.40% of the company’s 2.03B shares outstanding.
It has a market capitalization of $115.30B and a beta (3y monthly) value of 0.44. The earnings-per-share (ttm) stands at -$4.43. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.77% over the week and 2.24% over the month.
Earnings per share for the fiscal year are expected to increase by 492.00%, and -9.48% over the next financial year.
Looking at the support for the BMY, a number of firms have released research notes about the stock. Jefferies stated their Buy rating for the stock in a research note on December 16, 2024, with the firm’s price target at $70. BofA Securities coverage for the Bristol-Myers Squibb Co (BMY) stock in a research note released on December 10, 2024 offered a Neutral rating with a price target of $63. Leerink Partners on their part issued Outperform rating on November 12, 2024.
